WorldQuant Millennium Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.3M | Sell |
117,373
-73,732
| -39% | -$24M | 0.19% | 141 |
|
|
2025
Q1 | $51.6M | Buy |
191,105
+40,914
| +27% | +$11M | 0.33% | 91 |
|
|
2024
Q4 | $35.3M | Buy |
150,191
+91,671
| +157% | +$21.6M | 0.23% | 124 |
|
|
2024
Q3 | $16.1M | Sell |
58,520
-71,073
| -55% | -$19.5M | 0.12% | 197 |
|
|
2024
Q2 | $31.5M | Buy |
129,593
+69,520
| +116% | +$16.9M | 0.29% | 98 |
|
|
2024
Q1 | $8.98M | Sell |
60,073
-894
| -1% | -$134K | 0.11% | 207 |
|
|
2023
Q4 | $11.7M | Buy |
+60,967
| New | +$11.7M | 0.16% | 162 |
|
|
2023
Q3 | – | Sell |
-40,287
| Closed | -$7.65M | – | 353 |
|
|
2023
Q2 | $7.65M | Buy |
40,287
+21,949
| +120% | +$4.17M | 0.13% | 206 |
|
|
2023
Q1 | $3.67M | Buy |
+18,338
| New | +$3.67M | 0.07% | 237 |
|
|
2022
Q4 | – | Sell |
-20,426
| Closed | -$4.09M | – | 326 |
|
|
2022
Q3 | $4.09M | Buy |
+20,426
| New | +$4.09M | 0.1% | 215 |
|
|
2021
Q3 | – | Sell |
-31,999
| Closed | -$5.42M | – | 321 |
|
|
2021
Q2 | $5.42M | Buy |
31,999
+3,271
| +11% | +$554K | 0.12% | 192 |
|
|
2021
Q1 | $4.06M | Hold |
28,728
| – | – | 0.09% | 255 |
|
|
2020
Q4 | $3.73M | Hold |
28,728
| – | – | 0.08% | 260 |
|
|
2020
Q3 | $4.18M | Sell |
28,728
-13,951
| -33% | -$2.03M | 0.1% | 229 |
|
|
2020
Q2 | $6.32M | Buy |
42,679
+6,533
| +18% | +$968K | 0.15% | 195 |
|
|
2020
Q1 | $3.93M | Buy |
36,146
+23,424
| +184% | +$2.55M | 0.1% | 220 |
|
|
2019
Q4 | $1.47M | Buy |
+12,722
| New | +$1.47M | 0.03% | 279 |
|